Literature DB >> 22805811

Isolation and partial characterization of antibacterial lipopeptide produced by Paenibacillus polymyxa HKA-15 against phytopathogen Xanthomonas campestris pv. phaseoli M-5.

Vellaichamy Mageshwaran1, Suresh Walia, Kannepalli Annapurna.   

Abstract

An antibacterial metabolite was isolated from Paenibacillus polymyxa HKA-15, a soybean bacterial endophyte. The purification of the crude metabolite from Paenibacillus polymyxa HKA-15 was done by column chromatography. In TLC, a spot with an R ( f ) value of 0.86 (±0.02) from the purified fraction showed bioactivity against Xanthomonas campestris pv. phaseoli M-5. In SDS-PAGE, the purified antibiotic was separated in the molecular weight range of 3.5 kDa. The exact molecular weight of the active compound was identified as 1,347.7 Da using MS-MS analysis. Infra red spectrum and (1)H NMR analysis showed the presence of amino acids and fatty acids in the active compound. The characterization of the antibacterial compound revealed its lipopeptide nature. In an agar diffusion assay, the crude metabolite showed a broad spectrum of activity, being able to inhibit the growth of the fungal pathogen, Rhizoctonia bataticola, Macrophomina phaseolina and Fusarium udum. A stronger inhibition was observed against bacterial pathogens viz., X. campestris pv.phaseoli M-5, X. campestris pv. phaseoli CP-1-1, Xanthomonas oryzae, Ralstonia solanacearum and Micrococcus luteus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22805811     DOI: 10.1007/s11274-011-0888-y

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  19 in total

1.  Antimicrobial Activity of Culture Filtrate of Bacillus amyloliquefaciens RC-2 Isolated from Mulberry Leaves.

Authors:  S Yoshida; S Hiradate; T Tsukamoto; K Hatakeda; A Shirata
Journal:  Phytopathology       Date:  2001-02       Impact factor: 4.025

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  SDS-PAGE strongly overestimates the molecular masses of the neurofilament proteins.

Authors:  E Kaufmann; N Geisler; K Weber
Journal:  FEBS Lett       Date:  1984-05-07       Impact factor: 4.124

4.  Bacillomycin F, a new antibiotic of iturin group: isolation and characterization.

Authors:  A Mhammedi; F Peypoux; F Besson; G Michel
Journal:  J Antibiot (Tokyo)       Date:  1982-03       Impact factor: 2.649

5.  Bacilysocin, a novel phospholipid antibiotic produced by Bacillus subtilis 168.

Authors:  Norimasa Tamehiro; Yoshiko Okamoto-Hosoya; Susumu Okamoto; Makoto Ubukata; Masa Hamada; Hiroshi Naganawa; Kozo Ochi
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

6.  Paenibacillus polymyxa produces fusaricidin-type antifungal antibiotics active against Leptosphaeria maculans, the causative agent of blackleg disease of canola.

Authors:  Perrin H Beatty; Susan E Jensen
Journal:  Can J Microbiol       Date:  2002-02       Impact factor: 2.419

7.  Isolation and partial characterization of antagonistic peptides produced by Paenibacillus sp. strain B2 isolated from the sorghum mycorrhizosphere.

Authors:  S Selim; J Negrel; C Govaerts; S Gianinazzi; D van Tuinen
Journal:  Appl Environ Microbiol       Date:  2005-11       Impact factor: 4.792

8.  Purification and partial chemical characterization of the antimicrobial peptide cerein 8A.

Authors:  D Bizani; A P M Dominguez; A Brandelli
Journal:  Lett Appl Microbiol       Date:  2005       Impact factor: 2.858

9.  Antimicrobial activity of Paenibacillus peoriae strain NRRL BD-62 against a broad spectrum of phytopathogenic bacteria and fungi.

Authors:  I von der Weid; D S Alviano; A L S Santos; R M A Soares; C S Alviano; L Seldin
Journal:  J Appl Microbiol       Date:  2003       Impact factor: 3.772

10.  Bacillopeptins, new cyclic lipopeptide antibiotics from Bacillus subtilis FR-2.

Authors:  Y Kajimura; M Sugiyama; M Kaneda
Journal:  J Antibiot (Tokyo)       Date:  1995-10       Impact factor: 2.649

View more
  5 in total

Review 1.  Bioprospecting of endophytic microorganisms for bioactive compounds of therapeutic importance.

Authors:  Adekunle Raimi; Rasheed Adeleke
Journal:  Arch Microbiol       Date:  2021-03-07       Impact factor: 2.552

2.  Derringer desirability and kinetic plot LC-column comparison approach for MS-compatible lipopeptide analysis.

Authors:  Matthias D'Hondt; Frederick Verbeke; Sofie Stalmans; Bert Gevaert; Evelien Wynendaele; Bart De Spiegeleer
Journal:  J Pharm Anal       Date:  2013-09-18

3.  Polymyxin B1 and E2 From Paenibacillus polymyxa Y-1 for Controlling Rice Bacterial Disease.

Authors:  Wenshi Yi; Chao Chen; Xiuhai Gan
Journal:  Front Cell Infect Microbiol       Date:  2022-03-28       Impact factor: 6.073

4.  Polymyxin P is the active principle in suppressing phytopathogenic Erwinia spp. by the biocontrol rhizobacterium Paenibacillus polymyxa M-1.

Authors:  Ben Niu; Joachim Vater; Christian Rueckert; Jochen Blom; Maik Lehmann; Jin-Jiang Ru; Xiao-Hua Chen; Qi Wang; Rainer Borriss
Journal:  BMC Microbiol       Date:  2013-06-18       Impact factor: 3.605

5.  Common bacterial blight of bean: a model of seed transmission and pathological convergence.

Authors:  Nicolas W G Chen; Mylène Ruh; Armelle Darrasse; Justine Foucher; Martial Briand; Joana Costa; David J Studholme; Marie-Agnès Jacques
Journal:  Mol Plant Pathol       Date:  2021-05-04       Impact factor: 5.663

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.